A Study of Enlicitide Decanoate (MK-0616) and Semaglutide in Healthy Adult Participants (MK-0616-023)
Clinical trial NCT06699329 · COMPLETED
Trial details
- NCT number
- NCT06699329
- Sponsor
- Merck Sharp & Dohme LLC
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2024-01-22
- Primary completion
- 2024-05-24
- Enrollment
- 38
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.